Firefly Neuroscience (NASDAQ:AIFF) Releases Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) issued its quarterly earnings results on Tuesday. The company reported ($0.16) earnings per share for the quarter, Zacks reports. Firefly Neuroscience had a negative return on equity of 319.00% and a negative net margin of 2,705.88%.The business had revenue of $0.41 million for the quarter.

Firefly Neuroscience Trading Down 0.4%

Shares of NASDAQ:AIFF traded down $0.01 on Wednesday, reaching $2.17. 1,526,525 shares of the company were exchanged, compared to its average volume of 10,152,879. The company has a 50-day moving average of $1.28 and a 200-day moving average of $1.66. Firefly Neuroscience has a 1-year low of $0.62 and a 1-year high of $4.51. The firm has a market cap of $30.87 million, a price-to-earnings ratio of -1.06 and a beta of 1.92.

Institutional Investors Weigh In On Firefly Neuroscience

Several institutional investors have recently modified their holdings of AIFF. Jane Street Group LLC acquired a new stake in shares of Firefly Neuroscience in the 4th quarter worth approximately $53,000. Geode Capital Management LLC increased its stake in Firefly Neuroscience by 92.9% in the 2nd quarter. Geode Capital Management LLC now owns 120,604 shares of the company’s stock valued at $341,000 after purchasing an additional 58,067 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Firefly Neuroscience by 393.3% during the third quarter. Vanguard Group Inc. now owns 503,071 shares of the company’s stock worth $1,464,000 after purchasing an additional 401,085 shares during the last quarter. Hedge funds and other institutional investors own 4.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Firefly Neuroscience in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

About Firefly Neuroscience

Firefly Neuroscience is a clinical?stage neurotechnology company focused on developing digital biomarkers and cognitive assessment tools for the early detection and monitoring of neurological disorders. The company’s platform combines mobile applications, sensor technology and advanced analytics to capture objective brain function data outside of traditional clinical settings. By providing real?world cognitive and physiological measurements, Firefly aims to improve diagnosis, track disease progression and support therapeutic development.

The company’s flagship offering is a smartphone?based cognitive assessment app that guides users through a series of interactive tasks designed to measure attention, memory, processing speed and executive function.